Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
1 hedge funds and large institutions have $323K invested in Forward Pharma A/S American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
22% less capital invested
Capital invested by funds: $412K → $323K (-$89K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$119K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MCM
1
Mason Capital Management
New York
| $323K | – | – | – |
|
|
2
Acadian Asset Management
Boston,
Massachusetts
| – | -$119K | -61,468 | Closed |
|
FWP Hedge Fund Activity: Q1 2023 in Review
1 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q1 2023, worth a combined $323K — down 22% from $412K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FWP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Acadian Asset Management, exiting entirely with an estimated $119K sold.
- 1 institutional investor held Forward Pharma A/S American Depositary Shares (FWP) as of Q1 2023, down from 2 in Q4 2022.
- Funds reported $323K of Forward Pharma A/S American Depositary Shares stock for Q1 2023, down 22% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest Forward Pharma A/S American Depositary Shares seller in Q1 2023 was Acadian Asset Management, an estimated $119K sold.
Based on aggregated 13F filings for Q1 2023.